- Kraft Heinz Expands Kraft Singles Recall
- A Bold Move To Save A Man's Hand: Tucking It Into His Tummy
- Paramedics Talk Mental Effects Of Responding To Numerous Crashes
- Texas Teen Dies After Amoeba Enters Brain
- Texas AG To Shut Down Unlicensed North Austin Assisted Living Facility
- Student Contracts First Case Of Rubella In Texas Since 2004
- Mom Starts Movement To Save Lives Using Kindness
- Need For Blood Donations Increased Due To Rise In Traumatic Car Crashes
- Texas Records 4th Death This Year Linked To West Nile Virus
- Man Blames Austin Clinic For Loss Of Testicle
- Dr. James 'Red' Duke, Once-Familiar TV Doctor, Dead At 86
- Officials Confirm Dallas Resident Died Of West Nile Virus
- Students Miss Part Of First Day Of Class To Get Vaccines
- State Program Fails To Reduce Obesity At Texas Schools
- Austin Mom says Glass in Baby Wipes Injured Her Son
- Fluoridation Fight Heats Up In Austin And San Marcos
- El Paso Abortion Clinic Set To Become Texas' First To Reopen
- FDA Approves Female Sex Pill, But With Safety Restrictions
- Leander Boy Acts FAST To Save Grandma From Stroke
- FDA approves OxyContin for children 11 and older
- Austin Breast Milk Bank Recruiting Donors
- Solutions For Health Inequality In Austin
- West Nile Season Expected to Hit in Coming Weeks
- Local emergency room sees rise in heat related illness
- Alabama Health Officials OK Blue Bell Sales
- San Marcos Water Customers North Of Blanco River Under Boil Water Notice
- Guidelines Help Keep Student Athletes And Musicians From Getting Sick As Temps Soar
- FDA bans some Mexican cilantro after feces found in fields
- Flea Population Exploding Due To Recent Rains
- Snake Bite Deaths Rare
- New FDA Approved Injectable Dissolves Chin Fat
- Abbott: Texas Won't Legalize Medicinal Or Recreational Pot
- Rep. Spitzer Responds To Criticism Over Abstinence Education
- Texas Army Veteran Supports Medical Marijuana Legislation
- Justices Sharply Divided Over Health Care Law Subsidies
- Listeria Found In Blue Bell Plant In 2013
- Vaccinations Don't Stop After High School
- Kyle's Youth Ban On E-Cigs Proposed As State Law
- Miller Defends Deep Fryers In Agriculture Address
- Future Of ACA Subsidies In Texas Unclear After Rulings
- Women's Groups Blast Supreme Court Ruling On Contraception
- Austin Regional Clinic Strengthens Vaccination Policy
- Travis Co. Hit Hardest in Texas Cyclospora Outbreak
- 2 Cases of Chikungunya Reported In Central Texas
- Food For Families Food Drive kicks off June 15!
- PTSD treatment Bravemind set to deploy in Texas
- Austin Man Receives World's First Ever Skull, Scalp Transplant
- Woman Loses Eyesight From Cat Lick
- Man Who Caught Listeria-Related Meningitis Sues Blue Bell
- Blue Bell Closing All 3 Creameries For Training, Cleaning
Medical Breakthrough: Austin Brain Cancer Trial
The Austin Brain Tumor Center at Texas Oncology is leading the charge on a medical breakthrough. It's the first in the U.S. to test a drug targeting the most common and aggressive type of brain tumor.
"I just really couldn't move at all," said Zach.
Anne Tritschler couldn't believe what was happening to her husband.
"I came home from the gym and I found him lying on the kitchen floor," said Tritschler. "The gibberish that came out just freaked me out more than anything."
"We both thought that I had had a stroke," said Zach.
Zach doesn't want to use his last name.
A battery of tests led to a shocking diagnosis.
"They did an MRI and CT scan and that's when they found out through the CT that he had a brain tumor," said Tritschler.
"The type of brain tumor Glioblastoma that contains this type of tumor is clearly deadly," said Neuro-oncologist Morris D. Groves.
Groves is a physician with Texas Oncology and the Director of the Austin Brain Tumor Center. Dr. Groves also says Zach has a rare abnormality in his tumor.
"I was originally told I would live maybe five years," said Zach.
Understanding this abnormality is the focus of Dr. Groves' new, groundbreaking clinical trial.
"The breakthrough is the approach that targets the specific abnormality of the disease which is part of what makes it a tumor," said Groves.
He's testing the new drug from Novartis currently referred to as BGJ398 which targets the protein generated by this mutation.
"It works in the petri dish, it works in the animals," said Dr. Groves. "The question is will it work in people that's the only thing that matters."
Thirty-four patients across the world will be treated in the study. If it works, Zach could live another five years.
"It's awesome that Zach can be a part of this and hopefully it can help him," said Tritschler.
"This may be a part of a cure," said Dr. Groves.
The clinical trial started about three months ago. If you think you would qualify for the trial and would like to get tested, contact the Austin Brain Tumor Center at Texas Oncology.
-- Deeda Payton, KEYE TV News